CompuGroup Medical SE & Co KgaA/ DE000A288904 /
| 2024-12-20 5:29:47 PM | Chg. -0.04 | Volume | Bid5:30:00 PM | Ask5:30:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 21.70EUR | -0.18% | 186,218 Turnover: 1.54 mill. |
-Bid Size: - | -Ask Size: - | 1.13 bill.EUR | 4.63% | 24.52 |
Assets
|
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 88.1000 | 91.8000 | 100.1000 | 107.5000 | 108.4000 | ||||||
| Intangible Assets | 668.3000 | 1,088.1000 | 1,214.3000 | 1,293.9000 | 1,309.8500 | ||||||
| Long-Term Investments | 11.4000 | 12.9000 | 24.5000 | 65.2000 | 15.8500 | ||||||
| Fixed Assets | - | - | - | 1,523.6000 | 1,530.1100 | ||||||
| Inventories | 27.5000 | 18.2000 | 20.6000 | 29.4000 | 18.8800 | ||||||
| Accounts Receivable | 103 | 137.2000 | 147.2000 | 189.4000 | 175.4600 | ||||||
| Cash and Cash Equivalents | 46.4000 | 75.9000 | 107.3000 | 90.5000 | 64.4600 | ||||||
| Current Assets | 232.9000 | 308.1000 | 370.8000 | 420.8000 | 368.9700 | ||||||
| Total Assets | 1,065.9000 | 1,565.8000 | 1,790.8000 | 1,944.4000 | 1,899.9400 | ||||||
Liabilities
|
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 47.1000 | 64.5000 | 93.2000 | 112.6000 | 93 | ||||||
| Long-term debt | 424.5000 | 470.2000 | 587.1000 | 733.1000 | 704.1600 | ||||||
| Liabilities to Banks | 471.2000 | 515.3000 | 694.7000 | - | - | ||||||
| Provisions | 130.8000 | 149.5000 | 170.8000 | 201.8000 | 205.3100 | ||||||
| Liabilities | 805.9000 | 926.8000 | 1,192.1000 | 1,944.4000 | 1,229.1500 | ||||||
| Share Capital | 53.2190 | 53.7350 | 53.7350 | - | - | ||||||
| Total Equity | 259.9000 | 638.9000 | 612.3000 | 672.4000 | 667.6700 | ||||||
| Minority Interests | .8000 | .3000 | .2000 | 1.4000 | 1.5900 | ||||||
| Total liabilities equity | 1,065.9000 | 1,565.8000 | 1,790.8000 | 1,944.4000 | 1,899.9400 | ||||||
Income Statement
|
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 745.8000 | 837.3000 | 1,025.3000 | 1,129.7000 | 1,187.6600 | ||||||
| Depreciation (total) | 62.9000 | 75.5000 | 110.7000 | 112.4000 | 115.7900 | ||||||
| Operating Result | 115.3000 | 121.8000 | 102.7000 | 104 | 113.9600 | ||||||
| Interest Income | -5.7000 | -10.4000 | -4.8000 | 8.1000 | -41.3400 | ||||||
| Income Before Taxes | 107.7000 | 110.4000 | 97.9000 | - | - | ||||||
| Income Taxes | 41.6000 | 37 | 28.8000 | 32.7000 | 25.8000 | ||||||
| Minority Interests Profit | -.3000 | -.2000 | -.0600 | -.0700 | .9500 | ||||||
| Net Income | 65.8000 | 73.2000 | 69 | 73.4000 | 45.9100 | ||||||
Per Share
Cash Flow
|
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 110.5000 | 149.9000 | 165.3000 | 145 | 179.5200 | ||||||
| Cash Flow from Investing Activities | -139.4000 | -457.1000 | -164 | -145.4000 | -124.3200 | ||||||
| Cash Flow from Financing | 49.7000 | 338.1000 | 30.2000 | -16.4000 | -80.6800 | ||||||
| Decrease / Increase in Cash | 20.7000 | 30.9000 | 31.5000 | - | - | ||||||
| Employees | 5,627 | 7,814 | 8,598 | 9,229 | 9,199 | ||||||
